PISCAZZI, ANNAMARIA
PISCAZZI, ANNAMARIA
Dipartimento di Medicina Clinica e Sperimentale
Activation of the RAS/RAF/ERK signaling pathway contributes to resistance to sunitinib in thyroid carcinoma cell lines
2012-01-01 Piscazzi, Annamaria; Costantino, E; Maddalena, F; Natalicchio, I; Gerardi, Am; Antonetti, R; Cignarelli, Mauro; Landriscina, Matteo
Analysis of the mutational status of the BRAF oncogene in familiar non-medullary thyroid carcinomas.
2012-01-01 Landriscina, Matteo; Natalicchio, Mi; Piscazzi, Annamaria; Costantino, Eleonora; Cignarelli, Mauro
Comparative gene expression profiling of tobacco-associated HPV-positive versus negative oral squamous carcinoma cell lines
2020-01-01 Lepore, S.; Lettini, G.; Condelli, V.; Sisinni, L.; Piscazzi, A.; Simeon, V.; Zoppoli, P.; Pedicillo, M. C.; Natalicchio, M. I.; Pietrafesa, M.; Landriscina, M.
COMPARATIVE GENE EXPRESSION PROFILING OF TOBACCO-ASSOCIATED HPV-POSITIVE VERSUS NEGATIVE ORAL SQUAMOUS CARCINOMA CELL LINES.
2018-01-01 Lepore, Silvia; Lettini, Giacomo; Condelli, V; Sisinni, L; Piscazzi, Annamaria; Simeon, V; Maddalena, Francesca; Pedicillo, C; Natalicchio, I; Pietrafesa, M; Landriscina, Matteo
Cyclin-dependent kinase 1 targeting improves sensitivity to radiation in BRAF V600E colorectal carcinoma cells
2018-01-01 Spagnoletti, Girolamo; Li Bergolis, Valeria; Piscazzi, Annamaria; Giannelli, FRANCESCA VALERIA; Condelli, Valentina; Sisinni, Lorenza; Bove, Giuseppe; Storto, Giovanni; Landriscina, Matteo
DAAs increase serum VEGF level: a rationale for tumour risk recurrence during anti-HCV treatment
2017-01-01 Villani, Rosanna; Facciorusso, A; Bellanti, Francesco; Tamborra, Rosanna; Piscazzi, Annamaria; Landriscina, Matteo; Vendemiale, Gianluigi; Serviddio, Gaetano
DAAs rapidly reduce inflammation but increase serum VEGF level: A rationale for tumor risk during anti-HCV treatment
2016-01-01 Villani, Rosanna; Facciorusso, Antonio; Bellanti, Francesco; Tamborra, Rosanna; Piscazzi, Annamaria; Landriscina, Matteo; Vendemiale, Gianluigi; Serviddio, Gaetano
Differential and divergent activity of insulin-like growth factor binding protein 6 in platinum-sensitive versus platinum-resistant high-grade serous ovarian carcinoma cell lines
2022-01-01 Piscazzi, Annamaria; Condelli, Valentina; Crispo, Fabiana; Coda, Anna Rita Daniela; Calice, Giovanni; Bruno, Giuseppina; Venuto, Santina; Tibullo, Daniele; Giordano, Guido; Pietrafesa, Michele; Liso, Arcangelo; Landriscina, Matteo
Epidermal growth factor receptor 1 expression is upregulated in undifferentiated thyroid carcinomas in humans.
2011-01-01 Landriscina, Matteo; Pannone, Giuseppe; Piscazzi, Annamaria; Toti, P; Cignarelli, Mauro; Tortorella, S; Occhini, R; Ambrosi, Antonio; Bufo, Pantaleo; Cignarelli, M.
ER stress protection by TRAP1 induces resistance to paclitaxel in breast carcinoma cells
2013-01-01 Maddalena, F; Sisinni, L; Lettini, G; Condelli, V; Matassa, Ds; Piscazzi, Annamaria; Amoroso, Mr; Esposito, F; Landriscina, Matteo
Erlotinib enhances the proapoptotic activity of cytotoxic agents and synergizes with paclitaxel in poorly-differentiated thyroid carcinoma cells.
2010-01-01 Landriscina, Matteo; Maddalena, F.; Cignarelli, Mauro; Piscazzi, Annamaria; Lamacchia, Olga; Cignarelli, M.
Evidence‐based second‐line treatment in ras wild‐type/mutated metastatic colorectal cancer in the precision medicine era
2021-01-01 Giordano, G.; Parcesepe, P.; Bruno, G.; Piscazzi, A.; Lizzi, V.; Remo, A.; Pancione, M.; D'Andrea, M. R.; De Santis, E.; Coppola, L.; Pietrafesa, M.; Fersini, A.; Ambrosi, A.; Landriscina, M.
IDH1 Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment-Current State and Future Perspectives
2020-01-01 Crispo, Fabiana; Pietrafesa, Michele; Condelli, Valentina; Maddalena, Francesca; Bruno, Giuseppina; Piscazzi, Annamaria; Sgambato, Alessandro; Esposito, Franca; Landriscina, Matteo
IDH1 Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment-Current State and Future Perspectives
2020-01-01 Crispo, F.; Pietrafesa, M.; Condelli, V.; Maddalena, F.; Bruno, G.; Piscazzi, A.; Sgambato, A.; Esposito, F.; Landriscina, M.
KRAS and BRAF mutational status predicts the sensitivity of thyroid carcinoma cell lines to sunitinib.
2011-01-01 Piscazzi, Annamaria; Cignarelli, Mauro; Costantino, E; Maddalena, F; Natalicchio, Mi; Antonetti, R; Cignarelli, M; Landriscina, Matteo
NOTCH SIGNALLING MODULATES HYPOXIA-INDUCED NEUROENDOCRINE DIFFERENTIATION OF HUMAN PROSTATE CANCER CELLS
2012-01-01 Danza, G; Di Serio, C; Rosati, F; Lonetto, G; Sturli, N; Kacer, D; Pennella, Antonio; Ventimiglia, G; Barucci, R; Piscazzi, Annamaria; Prudovsky, I; Landriscina, Matteo; Marchionni, N; Tarantini, F.
Obstructive Sleep Apnea Worsens Progression-Free and Overall Survival in Human Metastatic Colorectal Carcinoma
2021-01-01 Lacedonia, D.; Landriscina, M.; Scioscia, G.; Tondo, P.; Caccavo, I.; Bruno, G.; Giordano, G.; Piscazzi, A.; Foschino Barbaro, M. P.
Pancreatic Enzyme Replacement and Nutritional Support With nab-Paclitaxel-based First-Line Chemotherapy Regimens in Metastatic Pancreatic Cancer
2023-01-01 Giordano, Guido; Cincione, Raffaele Ivan; Losavio, Francesca; Senia, Tiziano; Aquilini Mummolo, Arianna; Pacilli, Mario; Lizzi, Vincenzo; Bruno, Giuseppina; Piscazzi, Annamaria; Conteduca, Vincenza; Landriscina, Matteo
RAS/BRAF mutational status in familial non-medullary thyroid carcinomas: A retrospective study
2015-01-01 Landriscina, Matteo; Natalicchio, M. I.; Lamacchia, Olga; Conserva, A.; Piscazzi, Annamaria; Ciampolillo, A.; Zingrillo, M.; Pennella, Antonio; Bufo, Pantaleo; Vita, G.; Antonetti, R.; Maiorano, E.; Giorgino, F.; Cignarelli, Mauro
Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1
2013-01-01 Francesca, Maddalena; Lorenza, Sisinni; Giacomo, Lettini; Valentina, Condelli; Danilo Swann, Matassa; Piscazzi, Annamaria; Maria Rosaria, Amoroso; Giuseppe La, Torre; Franca, Esposito; Landriscina, Matteo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Activation of the RAS/RAF/ERK signaling pathway contributes to resistance to sunitinib in thyroid carcinoma cell lines | 1-gen-2012 | Piscazzi, Annamaria; Costantino, E; Maddalena, F; Natalicchio, I; Gerardi, Am; Antonetti, R; Cignarelli, Mauro; Landriscina, Matteo | |
| Analysis of the mutational status of the BRAF oncogene in familiar non-medullary thyroid carcinomas. | 1-gen-2012 | Landriscina, Matteo; Natalicchio, Mi; Piscazzi, Annamaria; Costantino, Eleonora; Cignarelli, Mauro | |
| Comparative gene expression profiling of tobacco-associated HPV-positive versus negative oral squamous carcinoma cell lines | 1-gen-2020 | Lepore, S.; Lettini, G.; Condelli, V.; Sisinni, L.; Piscazzi, A.; Simeon, V.; Zoppoli, P.; Pedicillo, M. C.; Natalicchio, M. I.; Pietrafesa, M.; Landriscina, M. | |
| COMPARATIVE GENE EXPRESSION PROFILING OF TOBACCO-ASSOCIATED HPV-POSITIVE VERSUS NEGATIVE ORAL SQUAMOUS CARCINOMA CELL LINES. | 1-gen-2018 | Lepore, Silvia; Lettini, Giacomo; Condelli, V; Sisinni, L; Piscazzi, Annamaria; Simeon, V; Maddalena, Francesca; Pedicillo, C; Natalicchio, I; Pietrafesa, M; Landriscina, Matteo | |
| Cyclin-dependent kinase 1 targeting improves sensitivity to radiation in BRAF V600E colorectal carcinoma cells | 1-gen-2018 | Spagnoletti, Girolamo; Li Bergolis, Valeria; Piscazzi, Annamaria; Giannelli, FRANCESCA VALERIA; Condelli, Valentina; Sisinni, Lorenza; Bove, Giuseppe; Storto, Giovanni; Landriscina, Matteo | |
| DAAs increase serum VEGF level: a rationale for tumour risk recurrence during anti-HCV treatment | 1-gen-2017 | Villani, Rosanna; Facciorusso, A; Bellanti, Francesco; Tamborra, Rosanna; Piscazzi, Annamaria; Landriscina, Matteo; Vendemiale, Gianluigi; Serviddio, Gaetano | |
| DAAs rapidly reduce inflammation but increase serum VEGF level: A rationale for tumor risk during anti-HCV treatment | 1-gen-2016 | Villani, Rosanna; Facciorusso, Antonio; Bellanti, Francesco; Tamborra, Rosanna; Piscazzi, Annamaria; Landriscina, Matteo; Vendemiale, Gianluigi; Serviddio, Gaetano | |
| Differential and divergent activity of insulin-like growth factor binding protein 6 in platinum-sensitive versus platinum-resistant high-grade serous ovarian carcinoma cell lines | 1-gen-2022 | Piscazzi, Annamaria; Condelli, Valentina; Crispo, Fabiana; Coda, Anna Rita Daniela; Calice, Giovanni; Bruno, Giuseppina; Venuto, Santina; Tibullo, Daniele; Giordano, Guido; Pietrafesa, Michele; Liso, Arcangelo; Landriscina, Matteo | |
| Epidermal growth factor receptor 1 expression is upregulated in undifferentiated thyroid carcinomas in humans. | 1-gen-2011 | Landriscina, Matteo; Pannone, Giuseppe; Piscazzi, Annamaria; Toti, P; Cignarelli, Mauro; Tortorella, S; Occhini, R; Ambrosi, Antonio; Bufo, Pantaleo; Cignarelli, M. | |
| ER stress protection by TRAP1 induces resistance to paclitaxel in breast carcinoma cells | 1-gen-2013 | Maddalena, F; Sisinni, L; Lettini, G; Condelli, V; Matassa, Ds; Piscazzi, Annamaria; Amoroso, Mr; Esposito, F; Landriscina, Matteo | |
| Erlotinib enhances the proapoptotic activity of cytotoxic agents and synergizes with paclitaxel in poorly-differentiated thyroid carcinoma cells. | 1-gen-2010 | Landriscina, Matteo; Maddalena, F.; Cignarelli, Mauro; Piscazzi, Annamaria; Lamacchia, Olga; Cignarelli, M. | |
| Evidence‐based second‐line treatment in ras wild‐type/mutated metastatic colorectal cancer in the precision medicine era | 1-gen-2021 | Giordano, G.; Parcesepe, P.; Bruno, G.; Piscazzi, A.; Lizzi, V.; Remo, A.; Pancione, M.; D'Andrea, M. R.; De Santis, E.; Coppola, L.; Pietrafesa, M.; Fersini, A.; Ambrosi, A.; Landriscina, M. | |
| IDH1 Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment-Current State and Future Perspectives | 1-gen-2020 | Crispo, Fabiana; Pietrafesa, Michele; Condelli, Valentina; Maddalena, Francesca; Bruno, Giuseppina; Piscazzi, Annamaria; Sgambato, Alessandro; Esposito, Franca; Landriscina, Matteo | |
| IDH1 Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment-Current State and Future Perspectives | 1-gen-2020 | Crispo, F.; Pietrafesa, M.; Condelli, V.; Maddalena, F.; Bruno, G.; Piscazzi, A.; Sgambato, A.; Esposito, F.; Landriscina, M. | |
| KRAS and BRAF mutational status predicts the sensitivity of thyroid carcinoma cell lines to sunitinib. | 1-gen-2011 | Piscazzi, Annamaria; Cignarelli, Mauro; Costantino, E; Maddalena, F; Natalicchio, Mi; Antonetti, R; Cignarelli, M; Landriscina, Matteo | |
| NOTCH SIGNALLING MODULATES HYPOXIA-INDUCED NEUROENDOCRINE DIFFERENTIATION OF HUMAN PROSTATE CANCER CELLS | 1-gen-2012 | Danza, G; Di Serio, C; Rosati, F; Lonetto, G; Sturli, N; Kacer, D; Pennella, Antonio; Ventimiglia, G; Barucci, R; Piscazzi, Annamaria; Prudovsky, I; Landriscina, Matteo; Marchionni, N; Tarantini, F. | |
| Obstructive Sleep Apnea Worsens Progression-Free and Overall Survival in Human Metastatic Colorectal Carcinoma | 1-gen-2021 | Lacedonia, D.; Landriscina, M.; Scioscia, G.; Tondo, P.; Caccavo, I.; Bruno, G.; Giordano, G.; Piscazzi, A.; Foschino Barbaro, M. P. | |
| Pancreatic Enzyme Replacement and Nutritional Support With nab-Paclitaxel-based First-Line Chemotherapy Regimens in Metastatic Pancreatic Cancer | 1-gen-2023 | Giordano, Guido; Cincione, Raffaele Ivan; Losavio, Francesca; Senia, Tiziano; Aquilini Mummolo, Arianna; Pacilli, Mario; Lizzi, Vincenzo; Bruno, Giuseppina; Piscazzi, Annamaria; Conteduca, Vincenza; Landriscina, Matteo | |
| RAS/BRAF mutational status in familial non-medullary thyroid carcinomas: A retrospective study | 1-gen-2015 | Landriscina, Matteo; Natalicchio, M. I.; Lamacchia, Olga; Conserva, A.; Piscazzi, Annamaria; Ciampolillo, A.; Zingrillo, M.; Pennella, Antonio; Bufo, Pantaleo; Vita, G.; Antonetti, R.; Maiorano, E.; Giorgino, F.; Cignarelli, Mauro | |
| Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1 | 1-gen-2013 | Francesca, Maddalena; Lorenza, Sisinni; Giacomo, Lettini; Valentina, Condelli; Danilo Swann, Matassa; Piscazzi, Annamaria; Maria Rosaria, Amoroso; Giuseppe La, Torre; Franca, Esposito; Landriscina, Matteo |